IRAY TECHNOLOGY COMPANY LIMITED Financials iRay Technology Company Limited
Equities
688301
CNE1000042V8
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 192.9 CNY | -2.50% |
|
+3.13% | -40.71% |
| 04-22 | IRay Technology Company Limited Debuts at Hannover Messe 2024 | CI |
| 02-28 | IRay Technology's 2023 Profit Slides 3.5%, EPS Misses Estimates; Shares Fall 5% | MT |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 12,456 | 36,049 | 33,284 | 33,157 | 19,654 | - | - |
| Enterprise Value (EV) 1 | 12,456 | 36,049 | 31,900 | 33,258 | 17,059 | 16,305 | 19,654 |
| P/E ratio | 45.5 x | 74.5 x | 52 x | 56.6 x | 22.9 x | 17.3 x | 16 x |
| Yield | - | 0.44% | 0.63% | 0.61% | 1.34% | 1.61% | 2.11% |
| Capitalization / Revenue | 15.9 x | 30.4 x | 21.5 x | 17.8 x | 8.43 x | 6.56 x | 5.94 x |
| EV / Revenue | 15.9 x | 30.4 x | 20.6 x | 17.8 x | 7.32 x | 5.44 x | 5.94 x |
| EV / EBITDA | 44.9 x | 61.7 x | 43.1 x | 45.4 x | 14.6 x | 12.2 x | 12.6 x |
| EV / FCF | - | 640 x | -79.6 x | -22 x | 27.9 x | 22.6 x | 20.6 x |
| FCF Yield | - | 0.16% | -1.26% | -4.54% | 3.59% | 4.43% | 4.86% |
| Price to Book | 4.73 x | 11.8 x | 9.19 x | 8.14 x | 3.84 x | 3.2 x | 2.95 x |
| Nbr of stocks (in thousands) | 101,567 | 101,567 | 101,768 | 101,941 | 101,906 | - | - |
| Reference price 2 | 122.6 | 354.9 | 327.1 | 325.3 | 192.9 | 192.9 | 192.9 |
| Announcement Date | 23/02/21 | 24/02/22 | 23/02/23 | 19/04/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 784.1 | 1,187 | 1,549 | 1,864 | 2,331 | 2,997 | 3,310 |
| EBITDA 1 | 277.7 | 584 | 739.9 | 732.7 | 1,164 | 1,331 | 1,561 |
| EBIT 1 | 246.4 | 549.9 | 708.7 | 683.6 | 892.2 | 1,205 | 1,372 |
| Operating Margin | 31.42% | 46.31% | 45.75% | 36.68% | 38.28% | 40.22% | 41.44% |
| Earnings before Tax (EBT) 1 | 254.6 | 559.9 | 708.7 | 685 | 965.1 | 1,262 | 1,377 |
| Net income 1 | 225.3 | 484 | 641.3 | 607.5 | 860 | 1,129 | 1,228 |
| Net margin | 28.73% | 40.77% | 41.4% | 32.59% | 36.89% | 37.68% | 37.11% |
| EPS 2 | 2.693 | 4.764 | 6.293 | 5.750 | 8.440 | 11.12 | 12.04 |
| Free Cash Flow 1 | - | 56.36 | -400.7 | -1,510 | 612 | 723 | 956 |
| FCF margin | - | 4.75% | -25.87% | -81.04% | 26.25% | 24.13% | 28.88% |
| FCF Conversion (EBITDA) | - | 9.65% | - | - | 52.55% | 54.3% | 61.24% |
| FCF Conversion (Net income) | - | 11.64% | - | - | 71.16% | 64.03% | 77.82% |
| Dividend per Share 2 | - | 1.571 | 2.071 | 2.000 | 2.582 | 3.112 | 4.070 |
| Announcement Date | 23/02/21 | 24/02/22 | 23/02/23 | 19/04/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 S1 | 2021 Q3 | 2021 Q4 | 2021 S2 | 2022 S1 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | - | 363.6 | 631.7 | - | 445.2 | 828.5 | - | - | - | - | 466.9 | 528 | - | - | - |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT | - | - | 191 | 316.2 | - | 146.8 | 413.3 | - | - | - | - | 204.1 | - | - | - | - |
| Operating Margin | - | - | 52.53% | 50.05% | - | 32.98% | 49.89% | - | - | - | - | 43.72% | - | - | - | - |
| Earnings before Tax (EBT) | - | - | 193.8 | 324.4 | - | 146.7 | 413.2 | - | 216.2 | 364.9 | - | 204.5 | - | - | - | - |
| Net income 1 | 209.8 | 116.1 | 158.2 | 274.3 | 276.4 | 133.3 | 364.9 | - | 187.9 | 324.6 | - | 174.6 | 164 | - | - | - |
| Net margin | - | - | 43.51% | 43.42% | - | 29.95% | 44.04% | - | - | - | - | 37.39% | 31.06% | - | - | - |
| EPS 2 | 2.064 | 1.143 | 1.557 | 2.700 | 2.721 | 1.293 | 3.571 | 1.620 | 1.560 | - | 1.060 | 1.500 | 2.870 | 1.990 | 1.640 | 2.650 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 04/08/21 | 21/10/21 | 24/02/22 | 24/02/22 | 28/08/22 | 23/02/23 | 23/02/23 | 26/04/23 | 28/08/23 | 28/08/23 | 14/10/23 | 19/04/24 | - | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | 101 | - | - | - |
| Net Cash position 1 | - | - | 1,384 | - | 2,595 | 3,348 | - |
| Leverage (Debt/EBITDA) | - | - | - | 0.1375 x | - | - | - |
| Free Cash Flow 1 | - | 56.4 | -401 | -1,510 | 612 | 723 | 956 |
| ROE (net income / shareholders' equity) | 21.8% | 17% | 19.3% | 15% | 17.6% | 18.8% | 18.6% |
| ROA (Net income/ Total Assets) | - | 15% | 13.7% | 8.3% | 11.4% | 12.8% | - |
| Assets 1 | - | 3,228 | 4,678 | 7,315 | 7,522 | 8,845 | - |
| Book Value Per Share 2 | 25.90 | 30.00 | 35.60 | 40.00 | 50.30 | 60.30 | 65.50 |
| Cash Flow per Share 2 | 2.580 | 2.440 | 3.110 | 3.340 | 6.550 | 14.60 | 8.230 |
| Capex 1 | - | 192 | 717 | 1,851 | 615 | 483 | 414 |
| Capex / Sales | - | 16.14% | 46.31% | 99.3% | 26.39% | 16.13% | 12.51% |
| Announcement Date | 23/02/21 | 24/02/22 | 23/02/23 | 19/04/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
192.9
CNY
Average target price
304.3
CNY
Spread / Average Target
+57.77%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -40.71% | 2.71B | |
| -5.77% | 14.68B | |
| -12.92% | 2.44B | |
| -8.78% | 1.51B | |
| -.--% | 1.12B | |
| +40.66% | 518M | |
| +11.68% | 239M | |
| +1.67% | 183M | |
| -.--% | 168M | |
| -34.20% | 163M |
- Stock Market
- Equities
- 688301 Stock
- Financials iRay Technology Company Limited
